KING PHARMACEUTICALS (KG) P/B (2011 - 2026)
KING PHARMACEUTICALS (KG) P/B from Feb 28, 2011 to Jul 21, 2026. The TTM KING PHARMACEUTICALS (KG) P/B is 0.62. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of KING PHARMACEUTICALS (KG)
| Year | P/B | Change |
|---|---|---|
| 2026 | 0.62 | +0.08% |
| 2025 | 0.62 | -96.63% |
| 2011 | 18.35 | N/A |
Comparison KING PHARMACEUTICALS (KG) P/B with competitors
KING PHARMACEUTICALS (KG) P/B is 0.62.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| GLRE | Greenlight Capital Re Ltd - Class A | 0.77 | +23.85% |
| EG | Everest Group Ltd | 0.98 | +58.12% |
| RGA | Reinsurance Group Of America Inc | 1.17 | +89.65% |
| SPNT | SiriusPoint Ltd | 1.26 | +104.04% |
| RNR | RenaissanceRe Holdings Ltd | 1.27 | +105.34% |
| HG | Hamilton Insurance Group Ltd - Class B | 1.27 | +105.50% |
| OXBR | Oxbridge Re Holdings Ltd | 2.09 | +238.56% |